[The treatment of children with Gilles de la Tourette's syndrome].
Tourette syndrome is a neuropsychiatric disorder of motor and vocal tics, with associated symptoms of obsessive-compulsive behaviors and attention deficit disorder with hyperactivity. Genetic factors seem to play a major role, but the precise mode of inheritance is still not known. Intervention includes reassurance and support of child and family, medication if needed and guidance and advocacy in relation to school achievements. The major goal of treatment is to help the child succeed in moving along the various lines of development. Clonidine, a centrally active alpha2-noradrenergic agonist is the first choice of medical treatment in most cases. If clonidine fails, pimozide and haloperidol are considered to be good alternatives.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000523:psychology; D002648:Child; D003000:Clonidine / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007859:Learning Disabilities / Q000523:psychology; D010868:Pimozide / Q000627:therapeutic use; D012931:Social Environment; D012944:Social Support; D005879:Tourette Syndrome / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*
D014150:Antipsychotic Agents; D010868:Pimozide; D006220:Haloperidol; D003000:Clonidine
De behandeling van kinderen met het syndroom van Gilles de la Tourette.